Hyperhomocysteinemia Potentiates Endothelial Dysfunction in Diabetes by Calpain and NADPH Oxidase Activation

Zhongjian Cheng,Xiaohua Jiang,Stanislav Sidorov,Pu Fang,William Durante,Xiaofeng Yang,Hong Wang
DOI: https://doi.org/10.1096/fasebj.23.1_supplement.937.1
2009-01-01
The FASEB Journal
Abstract:We studied the effect of hyperhomocysteinemia (HHcy) on endothelial function in type 1 diabetes. Severe and moderate HHcy were developed in male cystathionine beta‐synthase (CBS −/+ and CBS +/+ ) mice fed a high methionine (HM) diet at 8‐weeks of age for 8 weeks. Diabetes was induced by streptozotocin injection 4 weeks after dietary intervention. Severe HHcy markedly increased 24 h food and water intake, urine excretion, kidney and liver weight, and reduced blood glucose tolerance in diabetic mice. Endothelium‐dependent vascular relaxation to acetylcholine (ACh) was impaired by moderate HHcy and further potentiated by severe HHcy in thoracic aorta from HHcy diabetic mice. Endothelium‐independent vascular relaxation to sodium nitroprusside was impaired. HHcy impaired vascular relaxation to ACh was reversed by a superoxide scavenger tempol, a combination of PEG‐SOD and catalase, a NADPH oxidase inhibitor apocynin, and calpain inhibitors (MDL28170, ALLM and calpeptin) in diabetic mice. Severe HHcy also increased the protein levels of calpain and caspase 12, a marker of calpain activity, in the aortas of diabetic mice or the aortas of control mice incubated with L‐homocysteine (500 µM) and D‐glucose (44 mM) for 48h. Our data suggest that HHcy potentiates organ damage, metabolic disorders and endothelial dysfunction in diabetes, at least in part, by calpain and NADPH oxidase activation.
What problem does this paper attempt to address?